Pulmonary Fibrosis: Clinical Trials

129 trials for Pulmonary Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed, 27 unknown, 19 recruiting, 7 terminated. 129 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable129Completed 66, Unknown 27, Recruiting 19, Terminated 7, Not yet recruiting 5, Active not recruiting 4, Enrolling by invitation 1

Follow Pulmonary Fibrosis: new trials by email Literature Review of Pulmonary Fibrosis trials Research Report on Pulmonary Fibrosis

Trials (filtered) newest first · largest first

All 129 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diaphragmatic Release vs Inspiratory Muscle Training in Pulmonary Fibrosis
Diaphragmatic Release Technique (DRT), Targeted Inspiratory Muscle Training (IMT) - Pulmonary Fibrosis
Not applicableNot yet recruitingPharos University in Alexandria402026-11-202026-11-19
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
Spirometer, Oximeter, Scale - Fibrotic Interstitial Lung Disease, IPF and PPF
Not applicableRecruitingUniversity of California, San Francisco2002026-10-012026-10-09
New Diagnostic Approaches in the Management of Inflammatory Lung Diseases
Integrated Precision Medicine Platform - Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis
Not applicableNot yet recruitingFondazione Don Carlo Gnocchi ETS2002026-09-012026-07-23
Daoyin Technique for Improving Exercise Endurance in IPF
Daoyin Technique, Routine Comprehensive Training - Idiopathic Pulmonary Fibrosis
Not applicableRecruitingAffiliated Hospital of Liaoning University of Traditional Chinese Medicine2362026-04-222026-09-29
Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia
Peripheral Blood Collection - COPD, Idiopathic Pulmonary Fibrosis (IPF)
Not applicableRecruitingFondazione Don Carlo Gnocchi ETS1202026-04-222026-07-16
Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
Standard ILD Follow-Up Pathway, Optimized One-Day ILD Follow-Up Circuit - Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease
Not applicableActive not recruitingHospital de Granollers1522026-03-092026-10-21
Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
Standard ILD Diagnostic Pathway, Optimized ILD Diagnostic Circuit - Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease
Not applicableRecruitingHospital de Granollers922026-03-092026-10-21
Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days - Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Not applicableRecruitingUniversity Hospital Southampton NHS Foundation Trust162026-02-132026-07-06
Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
Quercetin (dietary supplement), Usual treatment - Fibrotic Interstitial Lungs Diseases, Idiopathic Pulmonary Fibrosis (IPF)
Not applicableRecruitingKaterina M. Antoniou1002026-01-262026-03-12
MOBoxy: MoblO2 to Maintain Oxygenation
MoblO2 control - COPD, Interstitial Lung Disease
Not applicableNot yet recruitingNational Jewish Health482025-12-012025-10-30
Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)
Blended patient education and self-management programme - Lung Fibrosis Interstitial
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern802025-10-072026-03-09
Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis
"motivational interviewing" - Idiopathic Pulmonary Fibrosis (IPF)
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1242025-10-012025-09-18
Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF
Jin-shui Huan-xian granule, Jin-shui Huan-xian granule placebo - Idiopathic Pulmonary Fibrosis(IPF)
Not applicableRecruitingHenan University of Traditional Chinese Medicine3842025-09-082026-10-16
Treatable Traits in Interstitial Lung Disease
Treatable traits model of care - Interstitial Lung Diseases (ILD)
Not applicableRecruitingThe University of Western Australia1102025-09-032025-10-07
Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies
No intervention: no treatment - Interstitial Lung Disease
Not applicableNot yet recruitingHopital Foch602025-05-312025-05-20
Downhill Walking in IPF
Pulmonary Rehabilitation, Downhill Walking, Treadmill Walking without incline - Idiopathic Pulmonary Fibrosis (IPF)
Not applicableCompletedSaglik Bilimleri Universitesi342025-05-132026-11-18
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
Home-based Pulmonary Rehab - Lung Fibrosis, Lung Interstitial Disease
Not applicableRecruitingMayo Clinic4602025-03-032026-03-20
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
A home monitoring strategy with event driven management - Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Systemic Sclerosis Pulmonary
Not applicableRecruitingOslo University Hospital2182024-12-162024-12-19
Pulmonary Outcomes on Patients With Lung Fibrosis
Routine medical care, Pulmonary rehabilitation - Lung Fibrosis
Not applicableActive not recruitingSouth Valley University602024-12-012025-07-28
Feasibility Randomised Controlled Trial Exploring Implementation of the Compassionate Mindful rEsilience pRogram for People With pUlmonaRY Fibrosis: The MERcURY Study
Compassionate mindful resilience - Pulmonary Fibrosis
Not applicableCompletedQueen's University, Belfast212024-12-012026-08-24

Showing 20 of 129. Sign in to see all of them.

Narrower conditions

Idiopathic Pulmonary Fibrosis (78)  ·  Lung Diseases, Interstitial (35)  ·  Pulmonary Disease, Chronic Obstructive (19)  ·  Motor Activity (9)  ·  Dyspnea (8)  ·  Bronchiectasis (7)  ·  Emphysema (6)  ·  Asthma (5)  ·  Lung Diseases (5)  ·  Sarcoidosis (5)  ·  Anxiety Disorders (4)  ·  COVID-19 (4)  ·  Cough (4)  ·  Fibrosis (3)

Broader conditions

Respiratory Tract Diseases (129)  ·  Lung Diseases (124)  ·  Lung Diseases, Interstitial (94)  ·  Pathological Conditions, Signs and Symptoms (71)  ·  Pathologic Processes (66)  ·  Fibrosis (57)  ·  Disease Attributes (22)  ·  Lung Diseases, Obstructive (22)  ·  Chronic Disease (21)  ·  Respiration Disorders (14)  ·  Immune System Diseases (12)  ·  Signs and Symptoms (12)  ·  Signs and Symptoms, Respiratory (12)  ·  Hypersensitivity (11)

Interventions

Exercise (7)  ·  Oxygen (3)  ·  Palliative Care (3)  ·  Air (2)  ·  Azithromycin (2)  ·  Blood Specimen Collection (2)  ·  Educational Status (2)  ·  Standard of Care (2)  ·  Accelerometry (1)  ·  Bronchoscopy (1)  ·  Capsules (1)  ·  Cognitive Behavioral Therapy (1)  ·  Continuous Positive Airway Pressure (1)  ·  Counseling (1)  ·  Dabigatran (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (4)  ·  Schön Klinik Berchtesgadener Land (4)  ·  Assiut University (2)  ·  Erasmus Medical Center (2)  ·  Fondazione Don Carlo Gnocchi ETS (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Heidelberg University (2)  ·  Henan University of Traditional Chinese Medicine (2)  ·  Hopital Foch (2)  ·  Hospital de Granollers (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Istanbul University - Cerrahpasa (2)  ·  Mayo Clinic (2)  ·  National Jewish Health (2)  ·  University Hospital Southampton NHS Foundation Trust (2)

Countries

United States (28)  ·  France (16)  ·  Canada (10)  ·  Turkey (Türkiye) (10)  ·  Germany (9)  ·  China (7)  ·  United Kingdom (7)  ·  Egypt (4)  ·  Greece (4)  ·  Netherlands (4)  ·  Spain (4)  ·  Australia (3)  ·  Italy (3)  ·  Belgium (2)  ·  Brazil (2)

Top investigators

Ganesh Raghu, MD (2)  ·  Jaume Bordas-Martinez, MD, PhD (2)  ·  Jeff Swigris, DO, MS (2)  ·  Michael Kreuter, Prof. (2)  ·  Thomas M. Egan, MD, MSc. (2)  ·  Adam Hurewitz, M.D. (1)  ·  Aikaterini Markopoulou, MD, PhD (1)  ·  Ali Hasan (1)  ·  Anita K Simonds, MBBS MD FRCP (1)  ·  Anna-Maria Hoffmann-Vold, MD, PhD (1)  ·  Anne E Holland, PhD (1)  ·  Antoine Delage, MDCM (1)  ·  Boris Duchemann (1)  ·  Borna Mehrad, MD (1)

Results publications

PMID 10380242, PMID 10501650, PMID 12091180, PMID 16634026, PMID 16806873, PMID 18245143, PMID 18432536, PMID 18808608, PMID 19008696, PMID 19863362, PMID 19998394, PMID 21131468, PMID 21333082, PMID 21471066, PMID 21719092, PMID 23204124, PMID 23386371, PMID 23550171, PMID 23975232, PMID 24293474, PMID 24314711, PMID 24705678, PMID 25185149, PMID 25731736, PMID 25956020, PMID 26869288, PMID 27165419, PMID 27348402, PMID 27748503, PMID 27794080, PMID 28775244, PMID 28945476, PMID 29321022, PMID 29531748, PMID 30100404, PMID 30166425, PMID 30506309, PMID 30600393, PMID 30835186, PMID 31241519, PMID 31900187, PMID 3208648, PMID 32311448, PMID 32325005, PMID 32422177, PMID 32534945, PMID 32703201, PMID 33108270, PMID 34003726, PMID 34015241

NIH funding

1UM1HL113115-01A1 (1), 1UM1HL119089 (1), 2016 (1), 2023 (1), K23HL175213 (1), K23NR016276 (1), R01HL098329 (1), R44HL160356 (1)